Merops Switch to
Inhibitors

Peptidase

Family Clan SEARCHES BLAST
MEROPS SUBMISSIONS

Other
information

Literature for U9G.066: cancer procoagulant

Summary Distribution Literature Substrates

(Topics flags: A Assay, T Target, I Inhibitor, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

    2018
  1. Krause,J. and Frost,C.L.<br>In vitro screening of synthetic fluorogenic substrates for detection of cancer procoagulant activity<br>Protein J (2018) 37, 151-163. PubMed  Europe PubMed DOI  A
    2. 2015
  2. Kee,N.L., Krause,J., Blatch,G.L., Muramoto,K., Sakka,K., Sakka,M., Naude,R.J., Wagner,L., Wolf,R., Rahfeld,J.U., Demuth,H.U., Mielicki,W.P. and Frost,C.L.<br>The proteolytic profile of human cancer procoagulant suggests that it promotes cancer metastasis at the level of activation rather than degradation<br>Protein J (2015) 34, 338-348. PubMed  Europe PubMed DOI
    3. 2012
  3. Findeisen,P., Costina,V., Yepes,D., Hofheinz,R. and Neumaier,M.<br>Functional protease profiling with reporter peptides in serum specimens of colorectal cancer patients: demonstration of its routine diagnostic applicability<br>J Exp Clin Cancer Res (2012) 31, 56-56. PubMed  Europe PubMed DOI
  4. Gordon,S.G. and Mielicki,W.P.<br>Cancer procoagulant<br>[ISSN:978-0-12-407742-3] (2012) 3, 3749-3752. DOI
  5. Kee,N.L.A., Naude,R.J., Blatch,G.L. and Frost,C.L.<br>The effect of cancer procoagulant on expression of metastatic and angiogenic markers in breast cancer and embryonic stem cell lines<br>Biol Chem (2012) 393, 113-121. PubMed  Europe PubMed DOI
    6. 2008
  6. Kamocka,M., Pollard,M., Suckow,M., Mielicki,W.P. and Rosen,E.D.<br>Rat prostate tumors express cancer procoagulant, an activator of coagulation factor X<br>Comp Med (2008) 58, 282-286. PubMed  Europe PubMed  PMC  EPMC
    7. 2006
  7. Kamocka,M., Kaplinska,K. and Mielicki,W.P.<br>Effect of immunisation with cancer procoagulant on the growth of Walker 256 carcinosarcoma cells in rats<br>Clin Exp Med (2006) 6, 119-123. PubMed  Europe PubMed DOI  T
  8. Snarska,J., Szajda,S.D., Knas,M., Mroczko,B., Borzym-Kluczyk,M., Kaminski,F., Zwierz,P. and Zwierz,K.<br>[Usefulness of detecting cancer procoagulant activity and thyrotropic hormone concentration in the differentiation of tumor-like changes in the thyroid]<br>Wiad Lek (2006) 59, 332-335. PubMed  Europe PubMed
    9. 2005
  9. [YEAR:10-5-2005]Kamocka,M., Rozalski,M., Krajewska,U., Wierzbicki,R. and Mielicki,W.P.<br>Effect of cancer procoagulant (CP) on the growth and adhesion of MCF-7 cells to vitronectin in vitro<br>Cancer Lett (10-5-2005) 222, 89-94. PubMed  Europe PubMed DOI
  10. Kazmierczak,M., Lewandowski,K., Wojtukiewicz,M.Z., Turowiecka,Z., Kolacz,E., Lojko,A., Skrzydlewska,E., Zawilska,K. and Komarnicki,M.<br>Cancer procoagulant in patients with adenocarcinomas<br>Blood Coagul Fibrinolysis (2005) 16, 543-547. PubMed  Europe PubMed
    11. 2004
  11. Gordon,S.G. and Mielicki,W.P.<br>Cancer procoagulant<br>[ISSN:0-12-079610-4] (2004) 2, 1405-1408.  V
    12. 2001
  12. Gale,A.J. and Gordon,S.G.<br>Update on tumor cell procoagulant factors<br>Acta Haematol (2001) 106, 25-32. PubMed  Europe PubMed DOI
  13. Mielicki,W.P.<br>Biochemistry of cancer procoagulant<br>Haemostasis (2001) 31 Suppl 1, 8-10. PubMed  Europe PubMed
  14. [YEAR:28-8-2001]Olas,B., Wachowicz,B. and Mielicki,W.P.<br>Cancer procoagulant and blood platelet activation<br>Cancer Lett (28-8-2001) 169, 165-171. PubMed  Europe PubMed DOI
    15. 2000
  15. Ogiichi,T., Hirashima,Y., Nakamura,S., Endo,S., Kurimoto,M. and Takaku,A.<br>Tissue factor and cancer procoagulant expressed by glioma cells participate in their thrombin-mediated proliferation<br>J Neurooncol (2000) 46, 1-9. PubMed  Europe PubMed DOI
  16. [YEAR:1-2-2000]Olas,B., Wachowicz,B., Mielicki,W.P. and Buczynski,A.<br>Free radicals are involved in cancer procoagulant-induced platelet activation<br>Thromb Res (1-2-2000) 97, 169-175. PubMed  Europe PubMed DOI
    17. 1999
  17. [YEAR:1-11-1999]Mielicki,W.P., Tenderenda,M., Rutkowski,P. and Chojnowski,K.<br>Activation of blood coagulation and the activity of cancer procoagulant (EC 3.4.22.26) in breast cancer patients<br>Cancer Lett (1-11-1999) 146, 61-66. PubMed  Europe PubMed DOI
    18. 1998
  18. [YEAR:1-7-1998]Falanga,A., Consonni,R., Marchetti,M., Locatelli,G., Garattini,E., Passerini,C.G., Gordon,S.G. and Barbui,T.<br>Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells<br>Blood (1-7-1998) 92, 143-151. PubMed  Europe PubMed
    19. 1997
  19. Mielicki,W.P., Mielicka,E. and Gordon,S.G.<br>Cancer procoagulant activity studies using synthetic peptidyl substrates<br>Thromb Res (1997) 87, 251-256. PubMed  Europe PubMed DOI
    20. 1994
  20. Gordon,S.G.<br>Cancer procoagulant<br>Methods Enzymol (1994) 244, 568-583. PubMed  Europe PubMed DOI  V
    21. 1993
  21. Mielicki,W.P. and Gordon,S.G.<br>Three-stage chromogenic assay for the analysis of activation properties of factor X by cancer procoagulant<br>Blood Coagul Fibrinolysis (1993) 4, 441-446. PubMed  Europe PubMed
    22. 1992
  22. [YEAR:30-4-1992]Moore,W.R.<br>The purification and properties of cancer procoagulant from murine tumors<br>Biochem Biophys Res Commun (30-4-1992) 184, 819-824. PubMed  Europe PubMed DOI
    23. 1991
  23. Gordon,S.G. and Mourad,A.M.<br>The site of activation of factor X by cancer procoagulant<br>Blood Coagul Fibrinolysis (1991) 2, 735-739. PubMed  Europe PubMed
    24. 1990
  24. Alessio,M.G., Falanga,A., Consonni,R., Bassan,R., Minetti,B., Donati,M.B. and Barbui,T.<br>Cancer procoagulant in acute lymphoblastic leukemia<br>Eur J Haematol (1990) 45, 78-81. PubMed  Europe PubMed
  25. [YEAR:13-8-1990]Donati,M.B., Falanga,A., Consonni,R., Alessio,M.G., Bassan,R., Buelli,M., Borin,L., Catani,L., Pogliani,E. and Gugliotta,L.<br>Cancer procoagulant in acute non lymphoid leukemia: relationship of enzyme detection to disease activity<br>Thromb Haemost (13-8-1990) 64, 11-16. PubMed  Europe PubMed
  26. [YEAR:1-10-1990]Gordon,S.G. and Cross,B.A.<br>An enzyme-linked immunosorbent assay for cancer procoagulant and its potential as a new tumor marker<br>Cancer Res (1-10-1990) 50, 6229-6234. PubMed  Europe PubMed
    27. 1989
  27. Falanga,A., Shaw,E., Donati,M.B., Consonni,R., Barbui,T. and Gordon,S.<br>Inhibition of cancer procoagulant by peptidyl diazomethyl ketones and peptidyl sulfonium salts<br>Thromb Res (1989) 54, 389-398. PubMed  Europe PubMed  I
    28. 1988
  28. Falanga,A., Alessio,M.G., Donati,M.B. and Barbui,T.<br>A new procoagulant in acute leukemia<br>Blood (1988) 71, 870-875. PubMed  Europe PubMed
    29. 1987
  29. Falanga,A., Bolognese Dalessandro,A.P., Casali,B., Roncaglioni,M.C. and Donati,M.B.<br>Several murine metastasizing tumors possess a cysteine proteinase with cancer procoagulant characteristics<br>Int J Cancer (1987) 39, 774-777. PubMed  Europe PubMed
    30. 1986
  30. Donati,M.B., Gambacorti-Passerini,C., Casali,B., Falanga,A., Vannotti,P., Fossati,G., Semeraro,N. and Gordon,S.G.<br>Cancer procoagulant in human tumor cells: evidence from melanoma patients<br>Cancer Res (1986) 46, 6471-6474. PubMed  Europe PubMed
    31. 1985
  31. Falanga,A. and Gordon,S.G.<br>Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue<br>Biochemistry (1985) 24, 5558-5567. PubMed  Europe PubMed
    32. 1981
  32. [YEAR:1-11-1981]Delaini,F., Colucci,M., de Bellis Vitti,G., Locati,D., Poggi,A., Semeraro,N. and Donati,M.B.<br>Cancer cell procoagulant: a novel vitamin K-dependent activity<br>Thromb Res (1-11-1981) 24, 263-266. PubMed  Europe PubMed
  33. Gordon,S.G. and Cross,B.A.<br>A factor X-activating cysteine protease from malignant tissue<br>J Clin Invest (1981) 67, 1665-1671. PubMed  Europe PubMed  PMC  EPMC
    34. 1980
  34. [YEAR:1-5-1980]Colucci,M., Curatolo,L., Donati,M.B. and Semeraro,N.<br>Cancer cell procoagulant activity: evaluation by an amidolytic assay<br>Thromb Res (1-5-1980) 18, 589-595. PubMed  Europe PubMed
  35. Hilgard,P. and Whur,P.<br>Factor X-activating activity from Lewis lung carcinoma<br>Br J Cancer (1980) 41, 642-643. PubMed  Europe PubMed  PMC  EPMC
    36. 1979
  36. Curatolo,L., Colucci,M., Cambini,A.L., Poggi,A., Morasca,L., Donati,M.B. and Semeraro,N.<br>Evidence that cells from experimental tumours can activate coagulation factor X<br>Br J Cancer (1979) 40, 228-233. PubMed  Europe PubMed  PMC  EPMC
    37. 1975
  37. Gordon,S.G., Franks,J.J. and Lewis,B.<br>Cancer procoagulant A: a factor X activating procoagulant from malignant tissue<br>Thromb Res (1975) 6, 127-137. PubMed  Europe PubMed

feedback
Page created 8-September-2023

EMBL-EBI logo

© 2025 EBI
Terms of use